Telix Pharmaceuticals Ltd
ASX:TLX
Telix Pharmaceuticals Ltd
ASX:TLX
Price:
15.05 AUD
-1.25%
Market Closed
Updated:
May 7, 2024
Telix Pharmaceuticals Ltd
Cash from Investing Activities
|
Telix Pharmaceuticals Ltd
Cash from Investing Activities Peer Comparison
Comparables:
IMM
MSB
CSL
CUV
PYC
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
Cash from Investing Activities
-AU$25.5m
|
CAGR 3-Years
-186%
|
CAGR 5-Years
-57%
|
CAGR 10-Years
N/A
|
|
|
Immutep Ltd
ASX:IMM
|
Cash from Investing Activities
-AU$82.7k
|
CAGR 3-Years
-109%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
N/A
|
|
|
Mesoblast Ltd
ASX:MSB
|
Cash from Investing Activities
-$45k
|
CAGR 3-Years
75%
|
CAGR 5-Years
40%
|
CAGR 10-Years
N/A
|
|
|
CSL Ltd
ASX:CSL
|
Cash from Investing Activities
-$1.4B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-13%
|
|
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
Cash from Investing Activities
AU$5.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
40%
|
|
|
PYC Therapeutics Ltd
ASX:PYC
|
Cash from Investing Activities
-AU$627.2k
|
CAGR 3-Years
70%
|
CAGR 5-Years
-379%
|
CAGR 10-Years
-7%
|
See Also
What is Telix Pharmaceuticals Ltd's Cash from Investing Activities?
Cash from Investing Activities
-25.5m
AUD
-25.5m
AUD
Based on the financial report for Dec 31, 2023, Telix Pharmaceuticals Ltd's Cash from Investing Activities amounts to -25.5m AUD.
What is Telix Pharmaceuticals Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-57%
-57%
Over the last year, the Cash from Investing Activities growth was -50%. The average annual Cash from Investing Activities growth rates for Telix Pharmaceuticals Ltd have been -186% over the past three years , -57% over the past five years .
You don't have any saved screeners yet
